Direct Referral for Apnea Monitoring
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Pittsburgh, Portland, and San Francisco, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 6,501 people enrolled
- Started
- 1 Aug 2020
- Ended
- 31 Mar 2026
- Type of study
- Observational, 3 groups
- Record updated
- 13 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Age 18 years Agrees to be seen by a VA sleep program Reason for referral to sleep clinic: New OSA Evaluation
Who cannot take part
- Age < 18 years Declines to be seen by a VA sleep program Reason for referral to sleep clinic: anything other than a new OSA evaluation
Where in United States
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, United States
- VA Portland Health Care System, Portland, ORPortland, United States
- San Francisco VA Medical Center, San Francisco, CASan Francisco, United States
About the trial
What the trial wants to find out
The primary objective of this project is to compare a health care delivery model, Direct Referral for Apnea Monitoring (DREAM), with initial in-person (Traditional) clinic appointments for Veterans at risk for obstructive sleep apnea (OSA). A secondary objective is to determine the negative predictive value (NPV) of home sleep apnea testing (HSAT).
The 3 groups in the trial
- Traditional clinical pathway for OSA
After referral, patients will have an initial encounter with a sleep care provider which might include in-person visits, telephone clinics, or video conferencing. Intervention/Treatment: Patients in Arm 1 will receive routine care for OSA at one of the participating VA Sleep Medicine clinics.
- DREAM clinical pathway for OSA
After referral, patients will not have an initial encounter with a care provider. After a clinician conducts a chart review of medical records, patients in the DREAM pathway will be referred for sleep testing. Intervention/Treatment: Patients in Arm 2 will receive routine care for OSA at one of the participating VA Sleep Medicine clinics.
- Negative predictive value of HSAT
Results of sleep tests will be compared for patients who undergo both HSAT and polysomnographic (PSG) procedures. Intervention/Treatment: Patients in Arm 3 will undergo a) HSAT sleep testing followed by PSG testing, or b) simultaneous administration of PSG and HSAT sleep testing.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Access to Sleep Apnea Care: A Pragmatic Study of New Consultation Models
- Record updated
- 13 May 2026